Forecast Bio, Inc.
SAN FRANCISCO, CA · CIK 0002152314 · Biotech
- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $2.4M
- 1 Form D · Aug 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20262027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,400,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2236 | L.E.A.F. Pharmaceuticals LLC | — | $40M |
| 2237 | LOXIGEN, INC. | — | — |
| 2238 | KAPHA BIO, INC. | — | — |
| 2239 | Forecast Bio, Inc. | — | $2.4M |
| 2240 | Monocacy Therapeutics Inc. | — | $389K |
| 2241 | POWERHOUSE PROTEOMIC SYSTEMS, LLC | — | — |
| 2242 | TENSIVE CONTROLS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.